(Q38051199)

27 August 2017

title

Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast (English)

1 reference

27 August 2017

Katrina Go Yamazaki

1

1 reference

27 August 2017

Eileen Gonzalez

series ordinal

2

1 reference

27 August 2017

Alexander C Zambon

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

29 September 2012

1 reference

Journal of Cardiovascular Translational Research

27 August 2017

published in

1 reference

27 August 2017

volume

5

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

805-813

1 reference

Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Physiology of local renin-angiotensin systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Angiotensin II and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

The cardiac fibroblast: therapeutic target in myocardial remodeling and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Diabetes and advanced glycoxidation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Cardiac fibroblast: the renaissance cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Cross-talk and modulation of signaling between somatostatin and growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Vascular smooth muscle cell activation by glycated albumin (Amadori adducts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Advanced glycation end-product-induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9405-4

Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts

21 January 2018

1 reference

12 December 2020

Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts

1 reference

12 December 2020

Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model

1 reference

12 December 2020

Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s).

1 reference

12 December 2020

Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.

1 reference

12 December 2020

Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers

1 reference

12 December 2020

Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells

1 reference

12 December 2020

Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients

1 reference

12 December 2020

Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study.

1 reference

12 December 2020

10.1007/S12265-012-9405-4

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1006834383

0 references

1 reference